For instance, if the mutant PML protein is resistant to As2O3 in vitro (i.e., no solubility changes), their corresponding PML mutants in APL patients also exhibit resistance to As2O3 [12,17]. This evidence concerns the gene PML and acute promyelocytic leukemia.